Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent α-glucosidase inhibitors to target hyperglycemia
Abstract Diabetes mellitus, particularly type 2 diabetes, is a growing global health challenge characterized by chronic hyperglycemia due to insulin resistance. One therapeutic approach to managing this condition is the inhibition of α-glucosidase, an enzyme involved in carbohydrate digestion, to re...
Saved in:
Main Authors: | Mehran Ghasemi, Mohammad Mahdavi, Maryam Dehghan, Mohammadreza Eftekharian, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Aida Iraji, Ahmed Al-Harrasi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-83917-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Piperazine derivatives as dangerous abused compounds
by: Welz Anna, et al.
Published: (2020-12-01) -
IN SILICO ELUCIDATION OF SOME QUINOLINE DERIVATIVES WITH POTENT ANTI-BREAST CANCER ACTIVITIES.
by: Momohjimoh Idris Ovaku, et al.
Published: (2020-01-01) -
Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation
by: Khalaf Reema Abu, et al.
Published: (2021-12-01) -
Different catalytic approaches of Friedländer synthesis of quinolines
by: Indhu Chandrasekaran, et al.
Published: (2025-01-01) -
Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents
by: Ghorab Mostafa M., et al.
Published: (2014-12-01)